Using a predefined, composite measure of clinical activity which included extent of chest radiograph abnormality, serum angiotensin converting enzyme, immunoglobulin levels and degree of peripheral lymphopenia (Table 1), 40 of the 51 patients were recruited spanning the entire predefined clinical activity score (0 to 12). This evidence concerns the gene ACE and lymphopenia.